How Robots Are Introducing A New Dimension To Healthcare Service Delivery
idiopathic-pulmonary-fibrosis-treatment-market
PDE4-B Inhibitors: A Promising Target...

Idiopathic pulmonary fibrosis (IPF) is a rare, sporadic, and fatal interstitial lung disease. As the morbid...

emerging-ulcerative-colitis-treatment-options
How the Novel Emerging Therapies Will...

Almost two decades ago, there were limited options for ulcerative colitis treatment. The readily available ...

Pharma News and Updates for Akero Chiesi Pfizer
AstraZeneca’s Danicopan Trial; CHMP R...

AstraZeneca’s Danicopan Shows Positive Results in Phase III Trial Danicopan, an oral Factor D inhibitor dev...

Alcohol Use Disorder Treatment Market Outlook
Adial’s Micro-formulation: Opening New Massive Alcohol Use Disorder Treatment Market Opportunities

Key Highlights Through the use of genetic screening, i.e., a companion genetic bio-marker intended to identify patients most likely to respond to therapy, AD04 humanizes the alcohol use disorde...


focal-segmental-glomerulosclerosis-market-outlook
Focal Segmental Glomerulosclerosis Market: Unfolding Insights into the Future

Currently, there are no FDA-approved therapies for FSGS. However, the therapeutic focal segmental glomerulosclerosis market in the seven major geographies mainly comprises off-label focal segmenta...


Pharma News for Amgen BioNTech and Gilead
Amgen Announced the Result of its CodeBreak-200 Trial; FDA Clears Bristol-Myers Squibb’s Deucrava...

Amgen Reveals the Top-line Result of its CodeBreak-200 trial of Lumakras in Lung Cancer The top-line result of Amgen's CodeBreak-200 trial of Lumakras in lung cancer was presented in abstract f...


severe-asthma-treatment-scenario
How Emerging Pipeline Therapies Will Unfold the Severe Asthma Treatment Market Dynamics?

Key Highlights Tezspire (tezepelumab) with no phenotypic (eosinophilic or allergic) or biomarker restriction will be the new game-changer in the severe asthma marketDepemokimab is an excellent ...


Pancreatic Cancer Therapeutics Market Outlook
Treatment to Clinical Development – A Bumpy Journey for Pancreatic Cancer

Treatment for pancreatic cancer patients is challenging and not well defined, especially for patients with disease progression or adverse events seen after initial treatment. Studies suggest that,...


promising-alopecia-areata-treatment-options
Alopecia Areata Treatment: Which Pipeline Therapy Will Steal the Spotlight?

Currently, there is no cure and no FDA-approved treatments for alopecia. Thus, the alopecia areata treatment market is completely dominated by off-label drug therapies. Depending on the extent of ...


TLR 7 and 8 Agonist
Toll-like receptors (TLR)...

Toll-like receptors (TLR) 7 and 8 are functionally localized to endosomes and recognize specific RNA.....

Gene Therapies Whitepaper
Gene Therapies

Gene therapies are regarded as one of the potential revolution in the Pharmaceutical field and Healt.....

Toll-like Receptors Agonist
Toll-like Receptors Agoni...

Toll-like Receptors (TLRs) are a type of pattern recognition receptor (PRR) that recognizes pathogen.....

Editor's Pick
Which Pipeline Therapy Has The Potential To Revolutionize The Dystrophic Epid...

Dystrophic epidermolysis bullosa (DEB) is a common skin disease with a chronic history ...

Can FcRn Antagonists Be The Game-Changer in the Generalized Myasthenia Gravis...

Though a rare disease, generalized myasthenia gravis (gMG) still affects around 60,000 ...

Exploring Potential New Avenues for Bronchopulmonary Dysplasia Treatment

Bronchopulmonary Dysplasia is the most common long-term respiratory morbidity of low-we...

A Market Space Beyond Lucentis and Eylea for Retinal Vein Occlusion Treatment

Competitive inroads by Regeneron’s Eylea in the retinal vein occlusion treatment landsc...

NexoBrid and its Awaiting US Approval

A Burn takes place when the skin comes into contact with a heat source. Burns can occur...